Financials

  • Market Capitalization 218.12 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.53
Rapporto prezzo/fatturato
8.08

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3471
GLSI
Greenwich LifeSciences, Inc. - Common stock
14.98 USD-15.70%-9.60%-1.12%+46.86%219.88 M USD
3475
ADCT
ADC Therapeutics SA Common Shares
1.71 USD-8.06%+36.80%+59.81%-61.74%218.31 M USD
3493
STRO
Sutro Biopharma, Inc. - Common Stock
11.45 USD-13.78%-22.32%-33.00%-34.16%189.85 M USD
3518
RNAC
Cartesian Therapeutics, Inc. - Common Stock
6.69 USD-4.29%-5.51%-18.32%-26.97%202.41 M USD